###begin article-title 0
A at Single Nucleotide Polymorphism-358 Is Required for G at -420 to Confer the Highest Plasma Resistin in the General Japanese Population
###end article-title 0
###begin p 1
Conceived and designed the experiments: HO YT RK TT JO WN YT MO KY RK KK TM HM HO. Performed the experiments: HO YT RK TT RK KK. Analyzed the data: HO YT RK TT JO MO HM HO. Contributed reagents/materials/analysis tools: HO YT RK TT RK KK TM HO. Wrote the paper: HO YT RK JO HM HO.
###end p 1
###begin p 2
Current address: Takanoko Hospital Institute of Diabetes Research Center, Ehime, Japan
###end p 2
###begin p 3
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 513 517 513 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 729 730 729 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 733 736 733 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;13</sup>
###xml 893 894 893 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 892 894 892 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 947 948 947 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 946 948 946 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 1142 1143 1142 1143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1141 1143 1141 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 1154 1155 1154 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1165 1169 1165 1169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;324</sup>
###xml 1186 1187 1186 1187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1185 1187 1185 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 1198 1199 1198 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1209 1213 1209 1213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;133</sup>
###xml 1557 1558 1557 1558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1588 1592 1588 1592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 117 121 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 235 240 <span type="species:ncbi:9606">human</span>
Insulin resistance is a feature of type 2 diabetes. Resistin, secreted from adipocytes, causes insulin resistance in mice. We previously reported that the G/G genotype of single nucleotide polymorphism (SNP) at -420 (rs1862513) in the human resistin gene (RETN) increased susceptibility to type 2 diabetes by enhancing its promoter activity. Plasma resistin was highest in Japanese subjects with G/G genotype, followed by C/G, and C/C. In this study, we cross-sectionally analyzed plasma resistin and SNPs in the RETN region in 2,019 community-dwelling Japanese subjects. Plasma resistin was associated with SNP-638 (rs34861192), SNP-537 (rs34124816), SNP-420, SNP-358 (rs3219175), SNP+299 (rs3745367), and SNP+1263 (rs3745369) (P<10-13 in all cases). SNP-638, SNP -420, SNP-358, and SNP+157 were in the same linkage disequilibrium (LD) block. SNP-358 and SNP-638 were nearly in complete LD (r2 = 0.98), and were tightly correlated with SNP-420 (r2 = 0.50, and 0.51, respectively). The correlation between either SNP-358 (or SNP-638) or SNP-420 and plasma resistin appeared to be strong (risk alleles for high plasma resistin; A at SNP-358, r2 = 0.5224, P = 4.94x10-324; G at SNP-420, r2 = 0.2616, P = 1.71x10-133). In haplotypes determined by SNP-420 and SNP-358, the estimated frequencies for C-G, G-A, and G-G were 0.6700, 0.2005, and 0.1284, respectively, and C-A was rare (0.0011), suggesting that subjects with A at -358, generally had G at -420. This G-A haplotype conferred the highest plasma resistin (8.24 ng/ml difference/allele compared to C-G, P<0.0001). In THP-1 cells, the RETN promoter with the G-A haplotype showed the highest activity. Nuclear proteins specifically recognized one base difference at SNP-358, but not at SNP-638. Therefore, A at -358 is required for G at -420 to confer the highest plasma resistin in the general Japanese population. In Caucasians, the association between SNP-420 and plasma resistin is not strong, and A at -358 may not exist, suggesting that SNP-358 could explain this ethnic difference.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 92 100 92 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 112 115 112 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Steppan1">[1]</xref>
###xml 117 120 117 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Steppan2">[2]</xref>
###xml 279 282 271 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Steppan2">[2]</xref>
###xml 325 329 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">retn</italic>
###xml 409 412 401 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Rangwala1">[3]</xref>
###xml 433 437 425 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">retn</italic>
###xml 483 486 475 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Banerjee1">[4]</xref>
###xml 674 677 666 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Curat1">[5]</xref>
###xml 679 682 671 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Nagaev1">[6]</xref>
###xml 684 687 676 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Patel1">[7]</xref>
###xml 3 7 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 182 186 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 284 288 <span type="species:ncbi:10090|species:ncbi:10095">Mice</span>
###xml 420 424 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 588 592 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 597 603 <span type="species:ncbi:9606">humans</span>
In mice, resistin is secreted from adipocytes, which antagonizes the action of insulin both in vitro and in vivo[1], [2]. While serum resistin levels are increased in obese diabetic mice, peroxisome proliferator-activated receptor gamma (PPARgamma) ligands reduce serum resistin [2]. Mice that overexpress the resistin gene (retn) in the liver are insulin-resistant through increased levels of serum resistin [3], while mice without retn show decreased fasting plasma glucose levels [4]. Therefore, elevated levels of serum resistin appear to be directly related to insulin resistance in mice. In humans, resistin appears to be mainly expressed in monocytes and macrophages [5], [6], [7].
###end p 5
###begin p 6
###xml 156 159 153 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-DeFronzo1">[8]</xref>
###xml 309 312 302 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-McCarthy1">[9]</xref>
###xml 508 512 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Prokopenko1">[10]</xref>
Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance in insulin target tissues, and impaired insulin secretion from pancreatic beta cells [8]. It has been reported that some single nucleotide polymorphisms (SNPs), such as PPARgamma Pro12Ala, KCNJ11 E23K, and TCF7L2 are associated with T2DM [9]. Recent genome-wide association studies (GWAS) have successfully identified approximately20 T2DM susceptibility SNPs, but the functional SNPs responsible for disease risk remain to be elucidated [10].
###end p 6
###begin p 7
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa1">[11]</xref>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa2">[12]</xref>
###xml 310 314 310 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa3">[13]</xref>
###xml 581 585 581 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 61 66 <span type="species:ncbi:9606">human</span>
We previously carried out systematic analyses of SNPs in the human resistin gene (RETN), and found that the G/G genotype of a promoter SNP at -420 (rs1862513) was associated with T2DM susceptibility [11], [12]. Functionally, Sp1/3 transcription factors specifically recognized G at -420, resulting in enhanced RETN promoter activity. In the general Japanese population, subjects with the G/G genotype had the highest plasma resistin levels, followed by C/G and C/C [13]. However, the specific cis-acting SNPs that are responsible for determining circulating resistin levels around RETN, remains to be elucidated.
###end p 7
###begin p 8
###xml 95 99 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 206 210 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Melzer1">[14]</xref>
###xml 324 328 312 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 410 414 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 422 426 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Tejero1">[15]</xref>
###xml 475 479 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 545 549 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa4">[16]</xref>
###xml 793 797 781 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 230 235 <span type="species:ncbi:9606">human</span>
Melzer et al. reported that a SNP rs2431866, located at a distance of approximately100 Kb from RETN, is associated with circulating resistin in a genome-wide protein QTL (quantitative trait locus) analysis [14]. In an analysis of human lymphocyte samples from 1,240 adults, Tejero et al. reported that a QTL that influences RETN mRNA is localized on chromosome 19p, where the strongest positional candidate is RETN itself [15]. In a previous study, we reported that monocyte RETN mRNA was positively correlated with its simultaneous serum level [16]. To our knowledge, no cis-acting SNPs have been shown to have stronger effects on their relevant gene products than SNP-420. Therefore, circulating resistin, as a model of protein QTL, merits further investigation, and SNPs in the vicinity of RETN would be of special interest.
###end p 8
###begin p 9
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
In view of this, to determine the SNPs responsible for circulating resistin around RETN, we cross-sectionally analyzed 2,019 Japanese subjects. Plasma resistin was found to be most strongly associated with SNP-358 and SNP-420, where the relevant allele, A at-358, was tightly linked to G at -420.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
SNP-358, and SNP-638 were in nearly complete linkage disequilibrium (LD), and were tightly correlated with SNP-420 in the general Japanese population
###end title 11
###begin p 12
###xml 36 43 36 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009718-t001">Table 1</xref>
###xml 123 124 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 150 151 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 356 362 356 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009718-g001">Fig. 1</xref>
###xml 695 696 695 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 694 696 694 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 749 750 749 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 748 750 748 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
We first typed the 8 SNPs listed in Table 1. All of these SNPs were considered to be in Hardy-Weinberg equilibrium because P = 0.049 for SNP+157, and P = 0.037 for SNP+1263 did not remain significant after Bonferroni's correction. Based on a confidence interval analysis, SNP-638, SNP -420, SNP-358, and SNP+157 were determined to be in the same LD block (Fig. 1). Four major haplotypes defined by SNP-638, SNP-420, SNP-358, and SNP+157 were found (haplotype, frequency; G-C-G-C, 0.670; A-G-A-C, 0.200; G-G-G-C, 0.073; G-G-G-T, 0.055). Approximately 94.5% of chromosomes can be captured by two tag SNPs, namely, SNP-358 (or SNP-638) and SNP-420. SNP-358 and SNP-638 were in nearly complete LD (r2 = 0.98), and were tightly correlated with SNP-420 (r2 = 0.50, and 0.51, respectively).
###end p 12
###begin title 13
SNP-358, and SNP-638 were nearly in complete LD, and were tightly correlated with SNP-420 in the general Japanese population.
###end title 13
###begin p 14
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Barrett1">[28]</xref>
###xml 323 324 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 385 386 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 419 420 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 488 489 488 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 500 501 500 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 499 501 499 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 545 546 545 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 544 546 544 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
The 8 SNPs around RETN were genotyped in 2,019 subjects in the general Japanese population, and LD between each pair of these SNPs were analyzed by Haploview [28]. One LD block consisting of SNP-638, SNP -420, SNP-358, and SNP+157 was defined by the confidence interval analysis. Each square represents a pairwise value of D', with the standard gradation (black indicates LOD> = 2 and D' = 1; none indicates, LOD<2 and D' = 1; white indicates LOD<2 and D' <1, gray indicates LOD> = 2 and D'<1). The r2 between SNP-638 and SNP-358 was 0.98. The r2 between SNP-420 and SNP-358 or SNP-638 was 0.50, and 0.51, respectively.
###end p 14
###begin title 15
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
Association between each SNP around RETN and plasma resistin in the general Japanese population.
###end title 15
###begin p 16
###xml 40 41 40 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 94 95 94 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
ANOVA is used for statistical analysis (n = 2,019). HWE, Hardy-Weinberg Equilibrium. *, these P values remained significant after Bonferroni's correction (raw P value x8).
###end p 16
###begin title 17
Nuclear proteins specifically recognized a difference in one base at SNP-358 but not at SNP-638
###end title 17
###begin p 18
###xml 201 207 201 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009718-g002">Fig. 2</xref>
To determine which SNP, i.e., SNP-358 or SNP-638, is potentially functional, we examined whether nuclear proteins specifically bound to DNA sequences using electrophoretic mobility shift assay (EMSA) (Fig. 2). Nuclear proteins were found to bind to a labeled probe with G at SNP-358 (-358G probe)(1st lane from the left), which was reduced by a cold competitor with G at SNP-358, but not by that with A at SNP-358 (2nd and 3rd lanes, respectively). This suggests that nuclear proteins specifically recognized a difference in one base at SNP-358. Consistent with this, no specific proteins bound to a labeled probe with A at SNP-358 (4th to 6th lanes). Regarding SNP-638, non-specific protein binding was found with a -638G probe (lane 7th), which was evenly reduced by a cold competitor with G at -628 (8th lane) and that with A at -638 (9th lane). The same non-specific protein binding was observed for a -638A probe (10th to 12th lanes). In addition, a computer search (MatInspector program ()) revealed the presence of transcription factor binding sites for SNP-358 but not for SNP-638. Therefore, we tentatively concluded that SNP-358 was a more functional SNP than SNP-638, and used SNP-358 when necessary in this study.
###end p 18
###begin title 19
Nuclear proteins specifically recognized a difference in one base at SNP-358 but not at SNP-638.
###end title 19
###begin p 20
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 35 42 35 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4"><italic>Methods</italic></xref>
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 171 173 171 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 171 173 171 173 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>32</sup></bold>
###xml 183 185 183 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 183 185 183 185 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>32</sup></bold>
###xml 291 293 291 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 291 293 291 293 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>32</sup></bold>
###xml 303 305 303 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 303 305 303 305 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>32</sup></bold>
EMSA was performed as described in Methods. A labeled probe representing RETN promoter sequences around SNP-358 contained G (major allele) or A (minor allele) at SNP-358 (32P-358G or 32P-358A, respectively), and that around SNP-638 contained G (major allele) or A (minor allele) at SNP-638 (32P-638G or 32P-638A, respectively). Each probe was incubated with a nuclear extract of THP-1 cells in the absence (-) or presence of a 200-fold molar excess of unlabeled competitor double-stranded oligonucleotides indicated (-358G, -358A, -638G, or -638A). The arrow points to the band that specifically bound to the probe with G at SNP-358.
###end p 20
###begin title 21
Plasma resistin was associated with SNP-638, SNP-537, SNP-420, SNP-358, SNP+299, and SNP+1263 in the general Japanese population
###end title 21
###begin p 22
###xml 84 91 84 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009718-t001">Table 1</xref>
###xml 147 148 147 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 158 162 158 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;329</sup>
###xml 174 175 174 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 185 188 185 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;14</sup>
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 211 215 211 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;133</sup>
###xml 227 228 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 238 242 238 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;324</sup>
###xml 254 255 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 265 268 265 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;85</sup>
###xml 285 286 285 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 296 299 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;16</sup>
###xml 308 309 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 375 376 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 393 394 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 392 394 392 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 445 446 445 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 444 446 444 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 816 823 792 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009718-t002">Table 2</xref>
We next examined the relation between plasma resistin levels and each of the 8SNPs (Table 1). Plasma resistin levels were associated with SNP-638 (P = 2.75x10-329), SNP-537 (P = 4.63x10-14), SNP-420 (P = 1.71x10-133), SNP-358 (P = 4.94x10-324), SNP+299 (P = 5.24x10-85), and SNP+1263 (P = 2.33x10-16). These P values remained significant after Bonferroni's correction. A low P value and high r2were found for SNP-358 (or SNP-638), and SNP-420 (r2 = 0.5224 (0.5275), and 0.2616, respectively). The difference in plasma resistin levels between each genotype appears to be highest for SNP-358 (or SNP-638), followed by SNP-420 (approximately8 ng/ml for SNP-358, and approximately5 ng/ml for SNP-420). These findings remained unchanged when assessed using multiple regression analyses adjusted for age, gender, and BMI (Table 2).
###end p 22
###begin title 23
Multiple regression analysis involving plasma resistin (ng/ml) as a dependent variable and each SNP as an independent variable (adjusted for age, gender, and BMI).
###end title 23
###begin p 24
###xml 218 225 218 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
Multiple regression analyses involving plasma resistin (ng/ml) as a dependent variable and each SNP genotype, age (years), gender (male = 0, female = 1), and BMI as independent variables were performed as described in Methods. For each SNP genotype, S/S was compared to N/N, and N/S was compared to N/N, respectively where the major and minor alleles based on the allele frequency were defined by normal (N), and susceptibility (S) alleles, respectively.
###end p 24
###begin p 25
###xml 208 209 208 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 293 300 293 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009718-t003">Table 3</xref>
###xml 671 679 671 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 679 683 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa2">[12]</xref>
###xml 685 689 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Azuma1">[17]</xref>
###xml 849 853 849 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
When the combination of SNP-420 and SNP-358 genotypes was analyzed, all subjects having the A/A genotype of SNP-358 also had the G/G genotype of SNP-420, and showed the highest plasma resistin levels (ANOVA, P<0.001, and Scheffe, P<0.001 compared to subjects with each of the other genotypes)(Table 3). Since only 4 of the 921 subjects with the C/C genotype of SNP-420 appeared to be heterozygotes of A at-358, and none was this homozygote, it was not possible to conclude the existence of an effect of A at-358, independent of G at -420. It is noteworthy that findings reported in two previous studies suggest that the effect of G at -420 is independent of A at SNP-358 in vitro[12], [17]. Therefore, the G of SNP-420 and the A of SNP-358 are both possible primary SNPs with the potential function of determining high plasma resistin levels around RETN in the general Japanese population.
###end p 25
###begin title 26
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
Plasma resistin in subjects with each combination of RETN SNP-420, and SNP-358 genotypes.
###end title 26
###begin p 27
###xml 273 274 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 291 292 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Plasma resistin (mean+/-SD) (ng/ml) is shown for each combination of SNP-420, and SNP-358 genotypes. The number of subjects is shown in parenthesis. Plasma resistin was higher in subjects with SNP-420G/G and SNP-358A/A genotypes than those with any other genotypes (ANOVA, P<0.001; Scheffe, P<0.001 compared to each of the other genotypes). N/A, not applicable because no subjects had this combination.
###end p 27
###begin title 28
The G-A haplotype defined by SNP-420 and SNP-358 conferred the highest plasma resistin in the general Japanese population
###end title 28
###begin p 29
###xml 219 226 219 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009718-t004">Table 4</xref>
###xml 745 746 733 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1000 1001 988 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
To determine which combination of these potentially functional SNPs is most responsible for plasma resistin, we examined the relation between plasma resistin and haplotypes defined by SNP-420 and SNP-358 in this order (Table 4). The estimated frequencies for C-G, G-A, and G-G were 0.6700, 0.2005, and 0.1284, respectively. Since the C-A haplotype was rare (0.0011), subjects having A at -358, generally had a G at -420. Conversely, approximately60% of chromosomes having G at -420 had A at -358. The highest risk haplotype, the G-A haplotype, conferred an 8.24 ng/ml higher plasma resistin level than a low risk reference haplotype, C-G (P<0.0001). Although C-A was estimated to show a 2.47 ng/ml higher plasma resistin level, compared to C-G (P = 0.2700), it was not possible to verify an effect of A at -358 itself, independent of G at -420, due to its low frequency (0.0011). The G-G haplotype, with G at -420, but not A at -358, showed an effect similar to that for C-G (-0.05 ng/ml difference, P = 0.8000). Therefore, G at -420 was not sufficient to confer the highest plasma resistin, and A at -358 was required in the general Japanese population. It is difficult to determine whether A at -358 alone or in combination with G at -420 is more responsible for this effect, based on only statistical analyses of genetic data.
###end p 29
###begin title 30
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
Estimated frequency and plasma resistin in each haplotype defined by RETN SNP-420, and SNP-358 genotypes.
###end title 30
###begin p 31
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Sole1">[29]</xref>
Frequency and plasma resistin for each haplotype defined by RETN SNP-420 and SNP-358 genotypes were estimated by SNPstats [29]. Estimated differences of plasma resistin compared to a reference haplotype, C-G, are shown in each haplotype.
###end p 31
###begin title 32
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
The RETN promoter with the G-A haplotype defined by SNP-420 and SNP-358 showed the highest activity in THP-1 cells
###end title 32
###begin p 33
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 307 308 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 353 354 349 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 373 374 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 385 391 381 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009718-g003">Fig. 3</xref>
###xml 712 720 708 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 143 148 <span type="species:ncbi:9606">human</span>
Finally, to determine the functional relevance of haplotypes defined by SNP-420 and SNP-358, we performed transfection experiments using THP-1 human monocytes. The RETN promoter activity with G at -420 and A at-358 showed the higher activity than the reference control promoter with C at -420 and G at-358 (n = 8, mean +/- SE, 1.62+/-0.16 fold; ANOVA , P = 0.002; Scheffe, P = 0.008) (Fig. 3). The promoter activity with the other two haplotypes, namely, G-G and C-A was not different from that with C-G. Since SNP-638 was not included in these promoter constructs, the observed effect was independent of A at SNP-638. Therefore, from statistical analyses of genetic data of the general Japanese population, and in vitro functional data, A at SNP-358 is required for G at -420 to confer the highest plasma resistin in the general Japanese population.
###end p 33
###begin title 34
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
The RETN promoter with the G-A haplotype defined by SNP-420 and SNP-358 showed the highest activity in THP-1 cells.
###end title 34
###begin p 35
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 210 217 210 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 476 477 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 499 500 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 144 149 <span type="species:ncbi:9606">human</span>
The RETN promoter reporter including -450/206 of RETN with each haplotype defined by SNP-420 and SNP-358 was transiently transfected into THP-1 human monocytes. Luciferase activity was measured as described in Methods. Relative luciferase activities are shown as the mean fold induction +/- SE relative to the activity of the reference promoter reporter with the C-G haplotype. The data represent eight independent experiments with triplicate wells for each condition. ANOVA, P = 0.002. *, Scheffe, P = 0.008 compared to C-G. The base numbers were shown where the translation initiation site was defined as +1.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 196 197 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 541 545 541 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
These findings herein indicate that plasma resistin levels are associated with SNP-638, SNP-537, SNP-420, SNP-358, SNP+299, and SNP+1263 around RETN in the general Japanese population. The lowest P value was observed for SNP-358 (or SNP-638), followed by SNP-420. SNP-420, and SNP-358 were in the same LD block, and a risk allele, A of SNP-358, was tightly linked with a risk allele, G of SNP-420. The G-A haplotype defined by SNP-420, and SNP-358, which included these risk alleles, conferred the highest plasma resistin. Functionally, the RETN promoter with this haplotype showed the highest activity in THP-1 cells. Nuclear proteins specifically recognized a difference in one base at SNP-358, but not at SNP-638.
###end p 37
###begin p 38
###xml 290 294 290 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 382 390 382 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa2">[12]</xref>
###xml 396 400 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Azuma1">[17]</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Cho1">[18]</xref>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Smith1">[19]</xref>
###xml 563 567 563 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 653 657 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa2">[12]</xref>
###xml 702 706 702 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 928 932 916 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
We found that SNP-358 was associated with plasma resistin in the order of A/A >G/A>G/G in a large number of Japanese subjects. Subjects having the relevant allele for high plasma resistin, i.e. an A at-358, generally had a G at -420. In four independent studies, the activity of the mutant RETN promoter including G at -420 was higher than that of the wild type including C at -420 in vitro[12], [17], [18], [19]. Of these, two studies have suggested that the effect of G at -420 is independent of A at SNP-358. In a previous study, we showed that Sp1/3 enhanced RETN promoter activity with G at -420 and G at-358 in the absence of SNP-638 in SL2 cells [12]. The findings reported herein indicate that RETN promoter activity with G at -420 and A at-358 without SNP-638 was approximately60% higher than that with the other combinations. Therefore, both the A of SNP-358 and the G of SNP-420 appear to be required for the highest RETN promoter activity.
###end p 38
###begin p 39
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Asano1">[20]</xref>
###xml 829 833 829 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Ioannidis1">[21]</xref>
During the preparation of this manuscript, Asano et al. reported on-line that rs34861192 (SNP-638G>A) and rs3745268 (3' UTR) are significant determinants of plasma resistin in an aged Japanese population [20]. Whereas their SNP typing data were similar to our results, the analysis and interpretation were different from those reported here. Based exclusively on statistical analyses of genetic data, they concluded that SNP-638 was a more promising candidate than SNP-420. However, SNP-638, SNP-420, and SNP-358 were all located in the same LD block, and all of these three SNPs were strongly associated with circulating resistin levels. It should be pointed out that it is difficult to identify a causal variant from highly correlated SNPs by the exclusive use of statistical analyses of genetic data without other information [21]. Therefore, a haplotype analysis and functional data were taken into account in assessing promising causal variants in the present study.
###end p 39
###begin p 40
###xml 445 449 441 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 544 548 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Lehrke1">[22]</xref>
###xml 970 971 962 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 526 531 <span type="species:ncbi:9606">human</span>
Since the A at -358 was tightly linked with the G at-420, the issue of whether the A of SNP-358 itself is largely responsible for high plasma resistin levels, or whether both the A of SNP-358 and the G of SNP-420 are required remains to be elucidated. Also, the possible relevance of SNP-358 is suggested, since the sequences around SNP-358 are similar to the NF-kappaB consensus sequences based on the MatInspector program (). The induction of RETN expression by lipopolysaccharides is inhibited by an NF-kappaB inhibitor in human macrophages [22]. Although no transcription factor binding sites were detected around SNP-638 by this program, it should be noted that SNP-638 had the same statistical association as SNP-358. The lack of apparent nuclear protein binding to the DNA sequence around SNP-638 may have resulted from inappropriate reaction conditions in detecting specific binding in the present study. SNP-638, and other SNPs including SNP+299 which show low P values clearly merit further investigation.
###end p 40
###begin p 41
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa2">[12]</xref>
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa3">[13]</xref>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa4">[16]</xref>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Cho1">[18]</xref>
###xml 344 348 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Menzaghi1">[23]</xref>
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Hivert1">[24]</xref>
###xml 725 729 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Hivert1">[24]</xref>
We previously reported that a functional promoter SNP-420 was tightly associated with plasma resistin, its final gene product, in Japanese subjects [12], [13], [16]. This association is also supported by a study reported by Cho et al. in an analysis of Korean subjects [18], but not that by Menzaghi et al. in an analysis of Caucasian subjects [23]. Most recently, Hivert et al. also reported that SNP-420 was not associated with circulating resistin in Caucasian subjects [24]. In their meta-analysis, which included Caucasians, Japanese, and Korean subjects, SNP-420 was found to be associated with plasma resistin with significant heterogeneity among the groups studied, suggesting that ethnic differences may be a factor [24]. In fact, whereas the A allele of SNP-358, which is tightly linked with the G allele of SNP-420, showed the strongest association with high plasma resistin in the present study, the A allele of SNP-358 was not found in the HapMap CEU population (). Therefore, SNP-358 is likely to be monophormic in Caucasians, which could account for the ethnic differences in the association between plasma resistin and SNP-420.
###end p 41
###begin p 42
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">retn</italic>
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Qatanani1">[25]</xref>
###xml 457 460 457 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Steppan1">[1]</xref>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa3">[13]</xref>
###xml 882 886 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Patel2">[26]</xref>
###xml 999 1003 999 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Gerber1">[27]</xref>
###xml 38 42 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 297 302 <span type="species:ncbi:9606">human</span>
###xml 450 456 <span type="species:ncbi:9606">humans</span>
###xml 877 881 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 917 922 <span type="species:ncbi:9606">human</span>
Most recently, in "humanized resistin mice", where human resistin is specifically expressed in macrophages and endogenous retn is disrupted, a high fat diet was found to induce insulin resistance with inflammation of adipose tissue [25]. Although this supports the pathophysiological relevance of human resistin in insulin resistance, it remains controversial whether circulating resistin is associated with insulin resistance, T2DM, or adiposity in humans [1], [13]. The discrepancy among previous reports may be resolved by analyzing SNPs that are correlated with circulating resistin. The lower power with a smaller numbers of subjects may also explain this difference. The broader range of the assay used in this study could also be a contributing factor. In addition, serum resistin probably exists as a hexamer (major form) or trimer (a more biologically active form) in mice [26]. The presence of multimers in human serum has been suggested, and this may also have affected the assay results [27].
###end p 42
###begin p 43
###xml 387 391 387 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
In summary, of the potentially functional SNPs, SNP-358 appears to be most strongly associated with plasma resistin in the general Japanese population, followed by SNP-420. Subjects having the responsible allele for the highest plasma resistin, A at -358, generally had G at -420. The G-A haplotype defined by SNP-420 and SNP-358 conferred the highest plasma resistin. Functionally, the RETN promoter with this G-A haplotype showed the highest activity. It is not clear why A of SNP-358 is required for G of SNP-420 to confer the highest plasma resistin, and whether the A of SNP-358 indeed accounts for ethnic differences in the association between plasma resistin and SNP-420. Further studies will be required to clarify these points.
###end p 43
###begin title 44
Methods
###end title 44
###begin title 45
Ethics Statement
###end title 45
###begin p 46
All subjects were informed of the purpose of the study and their written consent was obtained. The study was approved by the ethics committee of the Ehime University Graduate School of Medicine.
###end p 46
###begin title 47
Subjects
###end title 47
###begin p 48
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa3">[13]</xref>
###xml 718 725 718 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009718-t005">Table 5</xref>
This cross-sectional study included community-dwelling Japanese subjects who were attending an annual medical check-up in a rural town located in Ehime prefecture in Japan. We previously analyzed resistin SNP-420 and plasma resistin levels in 2,078 subjects in this population [13]. Of these subjects, 2,019 subjects, in whom all of the eight SNPs examined in the present study were successfully typed, were analyzed. The baseline characteristics of the study subjects, such as alcohol habituation, history or symptoms of cardiovascular disease (CVD), and medication-taking were investigated by an individual interview using a structured questionnaire. The clinical characteristics of these subjects are summarized in Table 5.
###end p 48
###begin title 49
###xml 43 44 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Characteristics of the population studied (n = 2,019).
###end title 49
###begin p 50
###xml 26 27 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Values are means+/-SD, or n (%). Number of subjects who measured immunoreactive insulin was 1,958. HOMA-IR (homeostasis model assessment insulin resistance index) was calculated as glucose (mg/dl) x insulin (microU/ml)/405. CVD indicates cardiovascular disease, including stroke, myocardial infarction, and angina pectoris.
###end p 50
###begin title 51
SNP typing
###end title 51
###begin p 52
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa1">[11]</xref>
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa2">[12]</xref>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa3">[13]</xref>
The seven SNPs were selected, based on our systemic analysis of SNPs in RETN[11], [12], and one SNP (rs3745369) in the 3' flanking region was added from HapMap (). These SNPs included all of the 4SNPs reported in HapMap around RETN. SNPs were typed by TaqMan analysis using assay on demand probes and primers sets (Applied Biosystems) except rs3760678, rs34861192, rs34124816, and rs3219177 which were generated as assay by design. The rs1862513 was previously typed as described [13]. Genotype call rates were rs3760678 (99.2%), rs34861192 (99.5%), rs34124816 (98.4%), rs3219175 (99.3%), rs3219177 (99.3%), rs3745367 (99.3%), and rs3745369 (99.7%).
###end p 52
###begin title 53
Measurement of plasma resistin
###end title 53
###begin p 54
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa2">[12]</xref>
###xml 47 52 <span type="species:ncbi:9606">human</span>
Fasting plasma resistin was determined using a human resistin ELISA kit (LINCO Research Inc., St. Charles, MO), according to the manufacturer's protocol [12]. The assay was linear below 0.16 ng/ml. Inter- and intra-assay coefficients of variation (CVs) were 6.9 and 1.7% (low levels), and 7.2 and 8.1% (high levels), respectively.
###end p 54
###begin title 55
Electrophoretic mobility shift assay (EMSA)
###end title 55
###begin p 56
###xml 103 104 97 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 173 176 167 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 334 371 326 363 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACTGTCTGCTCAGGAGCTTCCTCTTGGCCA-3&#8242;</named-content>
###xml 393 438 385 430 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GATCTGGCCAAGAGGAAGCTCCTGAGCAGACAGTGGTAC-3&#8242;</named-content>
###xml 456 493 448 485 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACTGTCTGCTCAGGGGCTTCCTCTTGGCCA-3&#8242;</named-content>
###xml 515 560 507 552 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GATCTGGCCAAGAGGAAGCCCCTGAGCAGACAGTGGTAC-3&#8242;</named-content>
###xml 578 615 570 607 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGTCACTGTAGCTTCAAACTCCCGGGCTCAA-3&#8242;</named-content>
###xml 637 682 629 674 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GATCTTGAGCCCGGGAGTTTGAAGCTACAGTGACGGTAC-3&#8242;</named-content>
###xml 700 737 692 729 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGTCACTGTAGCTTCGAACTCCCGGGCTCAA-3&#8242;</named-content>
###xml 759 804 751 796 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GATCTTGAGCCCGGGAGTTCGAAGCTACAGTGACGGTAC-3&#8242;</named-content>
###xml 868 870 860 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 936 938 924 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 66 72 <span type="species:ncbi:9913">bovine</span>
THP-1 cells were grown in RPM1 medium supplemented with 10% fetal bovine serum at 37degreesC in a 5% CO2 incubator. Nuclear extracts of THP-1 cells were prepared with NE-PER(R) Nuclear and Cytoplasmic Extraction Reagents (Thermo SCIENTIFIC). The following oligonucleotides were used for EMSA as probes or competitors, sense hRE-358A, 5'-CACTGTCTGCTCAGGAGCTTCCTCTTGGCCA-3'; antisense hRE-358A, 5'-GATCTGGCCAAGAGGAAGCTCCTGAGCAGACAGTGGTAC-3'; sense hRE-358G, 5'-CACTGTCTGCTCAGGGGCTTCCTCTTGGCCA-3'; antisense hRE-358G, 5'-GATCTGGCCAAGAGGAAGCCCCTGAGCAGACAGTGGTAC-3', sense hRE-638A, 5'-CGTCACTGTAGCTTCAAACTCCCGGGCTCAA-3'; antisense hRE-638A, 5'-GATCTTGAGCCCGGGAGTTTGAAGCTACAGTGACGGTAC-3'; sense hRE-638G, 5'-CGTCACTGTAGCTTCGAACTCCCGGGCTCAA-3'; antisense hRE-638G, 5'-GATCTTGAGCCCGGGAGTTCGAAGCTACAGTGACGGTAC-3'. Complementary oligonucleotides were annealed and labeled with 32P. A 10 microg of nuclear extract was incubated for 30 min with a 32P-labeled oligonucleotide (0.01 pmol) and 1 microg of poly(dAdT) in reaction buffer containing 25 mM HEPES (pH 7.9), 0.5 mM EDTA, 0.5 mM DTT, 40 mM KCl and 4% Ficoll (v/v). Nonidet P-40 (0.5%), and a 100-fold molar excess of the unlabeled single-stranded sense and antisense oligonucleotides, corresponding to each labeled probe were added to reduce nonspecific binding. Competition experiments were performed by the addition of a 200-fold molar excess of unlabelled double-stranded oligonucleotides to the reaction mixture. After the binding reaction, the mixture was subjected to 6% PAGE in 45 mM Tris, 45 mM boric acid, 1 mM EDTA at 100V for 2 h at 4degreesC. The gel was dried and exposed to a FUJIFILM imaging plate. Signals were detected with the FUJIFILM FLA-5100 image analyzing system.
###end p 56
###begin title 57
Plasmid construction
###end title 57
###begin p 58
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa2">[12]</xref>
###xml 572 610 572 610 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTTACTGTCTGCTCAGGAGCTTCCTCTTGGCCCCG</named-content>
###xml 616 655 616 655 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CGGGGCCAAGAGGAAGCTCCTGAGCAGACAGTAAG</named-content>
###xml 700 704 700 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 838 843 838 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn I</italic>
###xml 848 854 848 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bgl II</italic>
###xml 1115 1116 1115 1116 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1178 1182 1178 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Osawa2">[12]</xref>
The 5' flanking region between -450 and -206 of RETN was amplified by PCR using DNA from either a subject homozygous for a wild-type allele (-420C) or a subject homozygous for a mutant allele (-420G). These products were inserted into pGL3 basic vector (Promega, Madison, WI) to generate pGL3(-420G) and pGL3(-420C), both of which harbor G at the -358 locus, as described previously[12]. These constructs were modified by using QuickChange II Site-Directed Mutagenesis Kit (STRATAGENE, La Jolla, CA) to generate a point mutation at -358 from G to A. The primers used were 5'-CTTACTGTCTGCTCAGGAGCTTCCTCTTGGCCCCG, and 5'- CGGGGCCAAGAGGAAGCTCCTGAGCAGACAGTAAG. The DNA fragments between -450 and -206 of RETN with or without this point mutation were subsequently cloned into a luciferase reporter vector pGL4.11 (Promega) at the site between Kpn I and Bgl II. The sequence of the generated four plasmids, pGL4(-420C/-358G), pGL4(-420C/-358A), pGL4(-420G/-358G) and pGL4(-420G/-358A), were confirmed by DNA sequencing. All plasmids used for the transfection were prepared by use of a Qiagen plasmid kit, followed by CsCl2 density-gradient ultracentrifugation as described previously [12].
###end p 58
###begin title 59
Transient transfection and luciferase assay
###end title 59
###begin p 60
###xml 213 214 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 762 764 762 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 6 11 <span type="species:ncbi:9606">human</span>
###xml 37 42 <span type="species:ncbi:9606">Human</span>
###xml 592 596 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
THP-1 human monocytes purchased from Human Science Research Resources Bank (Osaka, Japan) were grown in RPMI1640 containing 10% FCS. One day before transfection, THP-1 cells were plated on a 6 well plate at 4.0x105 cells/well. Trans IT-Jurkat Reagent (Mirus, Madison, WI) was used for transient transfection following the manufacturer's protocol. Each of the pGL4(-420C/-358G), pGL4(-420C/-358A), pGL4(-420G/-358G) and pGL4(-420G/-358A) vectors was transfected into these cells along with pGL4.11 basic vector (control for basal activity), pGL4.11 promoter vector (positive control), and pRL-SV40 internal control vector. The THP-1 cells were then incubated with RPMI1640 containing 10% FCS for 48 hours. Luciferase assay were performed using the Dual-LuciferaseTM Reporter Assay System according to the manufacturer's protocol (Promega).
###end p 60
###begin title 61
Statistical analysis
###end title 61
###begin p 62
###xml 226 233 224 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009718-t001">Table 1</xref>
###xml 239 240 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1094 1098 1092 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Barrett1">[28]</xref>
###xml 1219 1223 1217 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009718-Sole1">[29]</xref>
###xml 1329 1330 1327 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 7 12 <span type="species:ncbi:9606">human</span>
In the human population study, values are expressed as the mean+/-standard deviation. Differences in plasma resistin levels among genotypes were assessed by analysis of variance (ANOVA). Bonferroni's correction was applied to Table 1 (raw P value x8). To assess isolated effects of each SNP on plasma resistin, multiple regression analyses involving each SNP, age (year), gender (male = 1, female = 0), and BMI as independent variables, and plasma resistin (ng/ml) as a dependent variable were performed. In these analyses, we assume that the major and minor alleles based on the allele frequency are normal (N), and susceptibility (S) alleles, respectively. Each SNP genotype, N/N, N/S, and S/S, were denoted by two dummy variables (c1, c2)  = (0, 0), (1, 0), and (0, 1), respectively. This first dummy variable estimates the difference between N/S and N/N, and the second between S/S and N/N. These analyses were performed using a commercially available statistical software package (JMP ver. 7, SAS Institute, Cary, NC). Linkage disequilibrium (LD) was assessed using the Haploview software [28]. Frequency and plasma resistin in each haplotype defined by SNP-420 and SNP-358 genotypes were estimated using SNPstats [29]. ANOVA followed by Scheffe as a post-hoc test was used where indicated. Null hypotheses were rejected at P<0.05.
###end p 62
###begin p 63
We thank Mr. Murase, and Mr. Nishimiya for suggestions. We also thank Ms. Hiraoka, Ms. Murakami, Ms. Takasuka, Ms. Takahashi, Ms. Kadota, and Mr. Omori for technical assistance.
###end p 63
###begin title 64
References
###end title 64
###begin article-title 65
The current biology of resistin.
###end article-title 65
###begin article-title 66
The hormone resistin links obesity to diabetes.
###end article-title 66
###begin article-title 67
Abnormal glucose homeostasis due to chronic hyperresistinemia.
###end article-title 67
###begin article-title 68
Regulation of fasted blood glucose by resistin.
###end article-title 68
###begin article-title 69
###xml 15 20 <span type="species:ncbi:9606">human</span>
Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin.
###end article-title 69
###begin article-title 70
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Resistin Is a Systemic Immune-Derived Proinflammatory Cytokine Targeting both Leukocytes and Adipocytes.
###end article-title 70
###begin article-title 71
###xml 25 30 <span type="species:ncbi:9606">human</span>
Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators.
###end article-title 71
###begin article-title 72
Pathogenesis of NIDDM. A balanced overview.
###end article-title 72
###begin article-title 73
Genetics of type 2 diabetes.
###end article-title 73
###begin article-title 74
Type 2 diabetes: new genes, new understanding.
###end article-title 74
###begin article-title 75
Systematic search for single nucleotide polymorphisms in the resistin gene: The absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes.
###end article-title 75
###begin article-title 76
The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3.
###end article-title 76
###begin article-title 77
Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population.
###end article-title 77
###begin article-title 78
A genome-wide association study identifies protein quantitative trait loci (pQTLs).
###end article-title 78
###begin article-title 79
###xml 102 107 <span type="species:ncbi:9606">human</span>
###xml 112 118 <span type="species:ncbi:9557">baboon</span>
Cross-species replication of a resistin mRNA QTL, but not QTLs for circulating levels of resistin, in human and baboon.
###end article-title 79
###begin article-title 80
Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.
###end article-title 80
###begin article-title 81
Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals.
###end article-title 81
###begin article-title 82
###xml 122 128 <span type="species:ncbi:9606">humans</span>
Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans.
###end article-title 82
###begin article-title 83
###xml 70 75 <span type="species:ncbi:9606">human</span>
A promoter genotype and oxidative stress potentially link resistin to human insulin resistance.
###end article-title 83
###begin article-title 84
Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population.
###end article-title 84
###begin article-title 85
Validating, augmenting and refining genome-wide association signals.
###end article-title 85
###begin article-title 86
###xml 56 62 <span type="species:ncbi:9606">humans</span>
An inflammatory cascade leading to hyperresistinemia in humans.
###end article-title 86
###begin article-title 87
Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians.
###end article-title 87
###begin article-title 88
Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study.
###end article-title 88
###begin article-title 89
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 100 104 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice.
###end article-title 89
###begin article-title 90
Disulfide-dependent multimeric assembly of resistin family hormones.
###end article-title 90
###begin article-title 91
###xml 40 48 <span type="species:ncbi:9606">children</span>
Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance.
###end article-title 91
###begin article-title 92
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 92
###begin article-title 93
SNPStats: a web tool for the analysis of association studies.
###end article-title 93
###begin p 94
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 94
###begin p 95
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Ehime University, Takeda Science Foundation, Setsuro Fujii Memorial, the Osaka Foundation for Promotion of Fundamental Medical Research, and by a fund from Mr. Takashi Ikeda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 95

